"The
Report PharmaPoint: Prophylactic Human Papillomavirus Vaccines -
Global Drug Forecast and Market Analysis to 2022 provides information
on pricing, market analysis, shares, forecast, and company profiles
for key industry participants. - MarketResearchReports.biz"
The first prophylactic vaccine
for immunization against human papillomavirus (HPV) became available
in 2006. The global HPV vaccines market is now well established, yet
vaccine coverage rates amongst the traditional target population of
adolescent girls remain persistently low. Initially HPV vaccines were
developed and marketed solely to protect against cervical cancer. In
recent years the role of HPV in other cancers has been increasingly
recognized which has facilitated a shift towards vaccinating a wider
population, most significant has been the inclusion of males in
routine vaccine recommendations in some countries. The current HPV
vaccines market is dominated by one major player, Mercks Gardasil,
with GlaxoSmithKlines (GSKs) HPV vaccine Cervarix providing the only
competition. The introduction of Mercks nine-valent vaccine (V503) is
set to change the future landscape of the HPV vaccines sector.
View Report At
:http://www.marketresearchreports.biz/analysis/208430
Highlights
Key
Questions Answered
-
What environmental factors limit the uptake of current HPV vaccines?
-
What opportunities exist to overcome these environmental factors?
-
What are the main unmet needs of current HPV vaccines?
-
What technologies are positioned to address these unmet needs?
-
What opportunities will remain for the development of new HPV
vaccines?
-
What environmental factors will influence the introduction of novel
HPV vaccines?
Key
Findings
-
New nine-valent HPV vaccines are expected to be widely adopted
following market approval, stealing market share from existing
vaccines. Though a high price represents a potential barrier to
market access.
-
Significant environmental barriers to HPV vaccination exist, which
currently serve to limit vaccine uptake.
-
The emphasis of HPV vaccination is shifting away from an initial
focus on cervical cancer prevention in females, towards prevention of
a range of cancers in both males and females.
-
The inclusion of males in routine HPV vaccine recommendations will
expand the size of the HPV vaccines market
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/208430
Scope
- Overview of the latest
advances in prophylactic vaccination.
- Analysis of the future
potential for novel and existing HPV vaccines.
- Key topics covered include
unmet needs, opportunities, and drivers and barriers specific to
prophylactic HPV vaccines.
Reasons to buy
- Understand the dynamics of
the prophylactic HPV vaccines market, and the unique barriers to
market access.
- Identify opportunities for
the development and delivery of HPV vaccines, and to identify
emerging players with potentially strong product portfolios.
- Develop business strategies
by understanding the trends shaping and driving the future of
prophylactic HPV vaccination.
- Formulate effective sales and
marketing strategies by understanding the competitive landscape and
by analysing the performance of various competitors.
- Gain insight on the
challenges associated with delivering prophylactic HPV vaccines and
the impact of novel vaccines.
- Track vaccine sales in the
global HPV vaccines market from 2012-2022
Table
of Contents
1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 13
1.2 List of Figures 16
2 Introduction 18
2.1 Catalyst 18
2.2 Related Reports 19
2.3 Upcoming Related Reports 19
3 Disease Overview 20
3.1 Etiology and
Pathophysiology 21
3.1.1 Etiology 21
3.1.2 Pathophysiology 21
3.2 Symptoms 23
4 Vaccination Recommendations
and Coverage Rates 25
4.1 Vaccination Recommendations
Overview 25
4.2 US 27
4.2.1 Vaccination
Recommendations and Policies 27
4.2.2 Vaccination Coverage 27
4.2.3 Clinical Practice 29
4.3 France 30
4.3.1 Vaccination
Recommendations and Policies 30
4.3.2 Vaccination Coverage 31
4.3.3 Clinical Practice 32
4.4 Germany 33
4.4.1 Vaccination
Recommendations and Policies 33
4.4.2 Vaccination Coverage 34
4.4.3 Clinical Practice 35
4.5 Italy 36
4.5.1 Vaccination
Recommendations and Policies 36
4.5.2 Vaccination Coverage 37
4.5.3 Clinical Practice 39
4.6 Spain 40
4.6.1 Vaccination
Recommendations and Policies 40
4.6.2 Vaccination Coverage 41
4.6.3 Clinical Practice 43
4.7 UK 43
4.7.1 Vaccination
Recommendations and Policies 43
4.7.2 Vaccination Coverage 44
4.7.3 Clinical Practice 45
4.8 Japan 46
4.8.1 Vaccination
Recommendations and Policies 46
4.8.2 Vaccination Coverage 47
4.8.3 Clinical Practice 48
4.9 Australia 49
4.9.1 Vaccination
Recommendations and Policies 49
4.9.2 Vaccination Coverage 49
4.9.3 Clinical Practice 51
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment